GAULTIER
Nîmes, CHU de Nîmes, 30029, France
NCT Number: NCT06056934
Today, the standard treatment is to operate on patients suffering from a fracture of the upper end of the femur. The aim of treatment is to enable immediate mobilization and weight-bearing, and as rapid a return as possible to normal living conditions.
Surgery is the best treatment option. It maximizes the chances of functional recovery and, by stabilizing the fracture, reduces pain: it is the most effective and longest-lasting analgesic.
Adequate analgesia in elderly patients with femoral neck fractures has a beneficial effect. In particular, a lower probability of death has been shown in cervical fracture patients receiving opioids than those not receiving them.
Pain management is a matter of protocol in the UPOG department of the CHU de Nîmes.
Pain prevention appears to improve morbidity and mortality. Cognitive fragility, such as neurocognitive disorders, confusion or long-term use of psychotropic drugs, appear to be confounding factors in pain management.
The investigators therefore wished to observe whether the presence of cognitive fragility has an impact on pain management on the ward, despite protocol-based management.
Looking for future studies?
Notify Me76 year and older
All sexes
Observational
Nîmes, CHU de Nîmes, 30029, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Pre-operative
mg/day
Time frame: Early post-operative between Day 0 and Day 3
mg/day
Time frame: Late post-operative between Day 4 and day 7
mg/day
Centre Hospitalier Universitaire de Nīmes
Other
Retrospective Study of Protocol-based Pain Management in Elderly Patients With or Without Cognitive Frailty Hospitalized at UPOG for Fracture of the Upper Extremity of the Femur in 2022
Acronym: ALGOGER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05818423
Cognition Disorders, Cognitive Decline
San Francisco, California, United States
View Trial DetailsNCT05497427
Alzheimer Disease, Brain Diseases
Palo Alto, California, United States
View Trial DetailsNCT06256666
Cognitive Deterioration
Volterra, Pisa, Italy
View Trial DetailsNCT02518243
Cognitive Deterioration
Nice, France
View Trial Details